查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1807636

細胞解離市場：按類型、產品類型、組織類型、技術、應用和最終用戶 - 2025-2030 年全球預測

Cell Dissociation Market by Type, Product, Tissue Type, Technology, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年細胞解離市場價值為 7.4686 億美元，預計到 2025 年將成長至 8.4903 億美元，複合年成長率為 13.94%，到 2030 年將達到 16.3488 億美元。

主要市場統計數據
基準年2024年 7.4686億美元
預計2025年 8.4903億美元
預測年份 2030 16.3488億美元
複合年成長率（%） 13.94%

細胞分離創新和市場動態為塑造組織工程的未來奠定了基礎

細胞解離是現代組織處理的核心，為科研和臨床實驗室從複雜的組織基質中分離活細胞提供了關鍵能力。透過分離單一細胞，該過程為下游應用奠定了基礎，例如先進的細胞療法、精準診斷和高通量藥物研發。對最大化產量、活力和功能完整性的通訊協定的追求推動了酶解、機械解離和化學解離方法的不斷創新。

描繪技術突破與策略驅動力的融合，引領細胞分離領域進入新時代

細胞解離領域正在經歷模式轉移，這得益於自動化、精密工程和數據驅動最佳化方面的突破。如今，自動化解離平台整合了先進的感測器和可程式設計通訊協定，能夠即時調節機械剪切力和酵素暴露。微流體系統的出現進一步增強了這一趨勢，該系統能夠在微升尺度上實現高度可控的解離，使研究人員能夠根據不同的組織類型和實驗目標客製化工作流程。

細胞分離領域的監管框架與競爭平衡，評估2025年貿易關稅將如何重塑供應鏈

2025年，美國對關鍵試劑、設備和組件徵收新的貿易關稅，對全球細胞分離供應鏈產生了連鎖反應。專用酵素和機器模組的進口關稅上調導致生產成本上升，並促使製造商重新評估定價策略。為了應對這些額外成本，製造商正在評估其他採購方案，並重新評估長期契約，以減輕財務影響。

利用深度細分觀點來理解支持細胞解離解決方案的多層市場結構

透過類型棱鏡分析市場，可以清楚了解細胞分離方法和綜合組織分離解決方案的性能概況，每種方法都能夠滿足特定的工作流程需求。按產品類型，設備起著關鍵作用，尖端的自動分離器可提供高通量，而手動組織研磨機則可為小批量或客製化應用提供靈活的操作。套件是另一個重要細分市場，其中連接複用套件簡化了多酶通訊協定，而一次性試劑套件優先考慮污染控制和操作簡單性。試劑構成最終產品，包括用於滲透平衡的緩衝液以及從膠原蛋白酶混合物到去氧核醣核酸酶分離物等各種酵素製劑。

了解美洲、歐洲、中東和非洲以及亞太地區的區域動態將決定細胞解離的採用趨勢

由於細胞療法研究的雄厚資金投入以及自動化細胞解離系統的廣泛應用，美洲地區在創新和需求方面繼續保持領先地位。北美的主要市場受益於一體化的供應網路、早期的技術應用以及支持研發和臨床級工具的強大法規環境。此外，拉丁美洲的研究中心正在加大對經濟高效的解離工作流程的投資，以支持當地的學術和生物製藥舉措，展現出多樣化的成長潛力。

介紹推動細胞分離技術突破和市場領導地位的關鍵創新者和策略合作者

領先的技術供應商紛紛推行差異化策略，以鞏固其在細胞解離領域的地位。一家知名公司專注於模組化自動化平台，該平台整合了先進的感測器陣列，並支援即時通訊協定調整和遠端監控功能。透過將這些儀器與專有試劑配方相結合，他們創造了以高可重複性和無縫工作流程整合為中心的價值提案。

實施策略舉措，提高業務效率，推動創新，確保細胞解離領域的競爭優勢

投資供應鏈韌性已成為產業領導者的基本建議。多元化採購管道並與區域供應商合作，可以幫助企業減輕未來關稅變動和夥伴關係中斷的影響。對關鍵酵素和設備零件實施近岸外包或雙重採購策略，可提高營運穩定性，並靈活應對監管變化。

一個綜合性的多模態研究框架，整合了初級研究和二級研究，並經過嚴格的檢驗以進行穩健的分析。

我們的研究框架融合了業界專家的實地研究、二手文獻分析和嚴格的檢驗通訊協定，以確保獲得全面可靠的見解。我們對細胞解離價值鏈上的高級研發負責人、產品經理和採購專家進行了深入訪談，以獲得關於產品引入、技術趨勢、供應鏈考量以及未滿足的市場需求的第一手觀點。

我們總結了主要發現和未來觀點，以幫助決策者了解細胞解離創新不斷發展的動態。

先進設備、客製化試劑系統以及不斷變化的貿易政策的融合，正在顯著改變細胞解離的模式。隨著自動化解離設備變得更加智慧化和模組化，以及酵素製劑的選擇性更高，市場有望提供更高的通量、可重複性和特定應用的性能。同時，新關稅的實施凸顯了供應鏈敏捷性和策略採購決策的重要性。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 可客製化的微流體設備，實現高通量單細胞分離與分析工作流程
  • 無酵素機械分離系統的出現，可以維持敏感原代培養物的細胞活力
  • 開發符合法規要求的低內毒素高純度試劑組
  • 引入整合 HEPA 過濾和環境監測的自動化、封閉式無菌解剖工作站
  • 開發專門的蛋白水解酶混合物，用於有效分離纖維狀人體心臟組織
  • 採用拋棄式解離耗材套件，最大限度地減少交叉污染和檢驗時間
  • 將即時電電阻感測器整合到解離裝置中，以精確控制組織分解
  • 擴大模組化酶解離平台用於CAR-T細胞療法的工業生物製造
  • 開發一種結合低剪切流反應器和針對神經組織的螯合劑的溫和解離通訊協定
  • 使用整合光學監測模組即時評估細胞活力和解離效率。

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章 細胞解離市場（依類型）

  • 細胞分離
  • 組織分離

第9章 細胞解離市場：依產品

  • 裝置
    • 自動分離器
    • 手動組織研磨機
  • 套件
    • 多重試劑套件
    • 套件
  • 試劑
    • 緩衝
    • 酵素

第10章。按組織類型分類的細胞解離市場

  • 結締組織
  • 上皮組織
  • 肌肉組織
  • 神經組織

第 11 章 細胞解離市場：依技術

  • 化學品
    • 螯合劑
    • 滲透劑
    • 界面活性劑
  • 酵素
    • 膠原酶
    • 分散酵素
    • DNase
    • 胰蛋白酶
  • 機器
    • 濾
    • 剪切
    • 超音波

第 12 章 細胞解離市場：依應用

  • 細胞療法
    • 汽車T製造
    • 幹細胞增殖
  • 基於細胞的研究
  • 臨床診斷
    • 流式細胞技術
    • 組織病理學
  • 藥物檢測
    • 高通量篩檢
    • 目標檢驗

第13章 細胞解離市場（依最終用戶）

  • 學術研究機構
  • 合約研究組織
  • 醫院和診斷中心
  • 製藥和生物技術公司

第 14 章：美洲細胞解離市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

15. 歐洲、中東和非洲細胞解離市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

16. 亞太細胞解離市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第17章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Corning Incorporated
    • Merck KGaA
    • Becton, Dickinson and Company
    • Thermo Fisher Scientific Inc.
    • Abeomics Inc.
    • Captivate Bio, LLC
    • Cell Signaling Technology, Inc.
    • Celprogen Corporation
    • Central Drug House.（P）Ltd.
    • Genaxxon bioscience GmbH
    • HiMedia Laboratories Private Limited
    • Innovative Cell Technologies, Inc.
    • Neuromics
    • Novo Nordisk A/S
    • PAN-Biotech GmbH
    • REPROCELL Inc.
    • RWD Life Science Co., Ltd.
    • Sartorius AG
    • ScienCell Research Laboratories, Inc.
    • Stemmera Inc.
    • VitaCyte, LLC
    • VWR International, LLC
    • Worthington Biochemical Corporation

第18章 研究人工智慧

第19章 研究統計

第20章 研究聯絡人

第21章 研究報導

第22章 附錄

Product Code: MRR-46132FF79DDC

The Cell Dissociation Market was valued at USD 746.86 million in 2024 and is projected to grow to USD 849.03 million in 2025, with a CAGR of 13.94%, reaching USD 1,634.88 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 746.86 million
Estimated Year [2025] USD 849.03 million
Forecast Year [2030] USD 1,634.88 million
CAGR (%) 13.94%

Setting the Stage for Cell Dissociation Innovations and Market Dynamics Shaping the Future of Tissue Processing Technologies

Cell dissociation stands at the heart of modern tissue processing, providing critical capabilities that enable research and clinical laboratories to isolate viable cells from complex tissue matrices. By separating individual cells, this process forms the foundation for downstream applications such as advanced cell therapies, precision diagnostics, and high-throughput drug discovery efforts. The quest for protocols that maximize yield, viability, and functional integrity has driven continuous innovation across enzymatic, mechanical, and chemical dissociation methodologies.

This executive summary offers a concise yet comprehensive overview of the forces shaping the cell dissociation landscape. It examines the latest breakthroughs in automation technologies, the growing role of proprietary reagent formulations, and the impact of evolving regulatory environments on product development and market entry. By integrating insights from primary interviews and secondary research, this section delineates the interplay between cost pressures, quality requirements, and strategic imperatives.

Moreover, the proliferation of single-cell analysis platforms has heightened demand for robust dissociation workflows capable of delivering consistent, high-quality specimens. Furthermore, cross-functional collaboration between academic institutions and commercial enterprises is accelerating the translation of novel dissociation techniques into scalable solutions. Together, these factors establish the context for the deep-dive analyses that follow, framing the strategic pathways and tactical considerations critical for success in this dynamic sector.

Mapping the Convergence of Technological Breakthroughs and Strategic Drivers Steering the Cell Dissociation Sector into a New Era

The cell dissociation field is undergoing a paradigm shift fueled by breakthroughs in automation, precision engineering, and data-driven optimization. Automated dissociator platforms now integrate sophisticated sensors and programmable protocols, enabling real-time adjustment of mechanical shear forces and enzymatic exposure. This trend is reinforced by the advent of microfluidic systems that facilitate highly controlled dissociation at microliter scales, empowering researchers to tailor workflows for diverse tissue types and experimental objectives.

Parallel to hardware advancements, reagent developers are designing next-generation enzymatic blends and chemical chelators that deliver improved specificity and reduced cellular stress. Chelating agents optimized for selective calcium ion removal are being combined with proteolytic enzymes in multiplex reagent formulations to strike a balance between processing time and cell viability. Concurrently, artificial intelligence and machine learning algorithms are emerging as powerful tools to predict dissociation outcomes based on tissue morphology data, driving continuous refinement of protocol parameters.

In addition to technological innovation, strategic alliances between equipment manufacturers, reagent suppliers, and academic consortia are converging to expedite product validation and regulatory approval. The convergence of digital analytics, modular instrumentation, and enhanced reagent chemistries is redefining performance benchmarks. As a result, stakeholders are repositioning their operations to harness integrated solutions that promise higher throughput, reproducibility, and cost-efficiency.

Evaluating How 2025 Trade Tariffs Reshape Supply Chains Regulatory Frameworks and Competitive Equilibriums within the Cell Dissociation Field

The imposition of new trade tariffs on key reagents, instruments, and components introduced in 2025 has created a ripple effect across global cell dissociation supply chains. Heightened import duties on specialized enzymes and mechanical modules have translated into elevated production costs and recalibrated pricing strategies. As manufacturers contend with these additional expenses, they are evaluating alternative sourcing options and reassessing long-term contracts to mitigate financial impact.

In response, many original equipment manufacturers and reagent producers have accelerated efforts to localize critical production processes. This nearshoring trend reduces exposure to fluctuating trade policies and shortens lead times, while also enabling more agile quality control and regulatory compliance. At the same time, distributors are seeking to diversify their vendor portfolios, establishing partnerships with regional suppliers that offer comparable performance at more favorable duty classifications.

Regulatory adaptations have accompanied these strategic shifts, with customs authorities refining tariff codes to distinguish between research-grade and clinical-grade materials. Industry participants have proactively engaged with trade associations to advocate for tariff exemptions on life science tools deemed essential for public health initiatives. Moving forward, the interplay between evolving trade frameworks and supply chain resilience will shape procurement strategies and competitive positioning within the cell dissociation market.

Harnessing Deep Segmentation Perspectives to Decode the Multi-Layered Market Structure Underpinning Cell Dissociation Solutions

Analyzing the market through a type-based prism reveals distinct performance profiles for cell detachment methods versus comprehensive tissue dissociation solutions, each catering to specialized workflow requirements. When dissected by product category, instruments play a pivotal role, with state-of-the-art automated dissociators offering high throughput contrasted against manual tissue grinders that deliver flexible handling for low-volume or bespoke applications. Kits constitute another critical segment, where multiplex kits streamline multi-enzyme protocols and single-use kits prioritize contamination control and operational simplicity. Reagents form the final product leg, encompassing buffers designed for osmotic balance alongside enzyme preparations that range from collagenase blends to DNase isolates.

Expanding the segmentation to tissue type underscores varied processing challenges across connective, epithelial, muscle, and nervous tissues, each demanding tailored combinations of mechanical and biological treatments. Technology-driven breakdown further segments the field into chemical agents such as chelating or surfactant compounds, enzymatic systems built around proteases like trypsin or dispase, and mechanical approaches that leverage filtration, shear stress, or ultrasonic cavitation.

A focus on application unveils distinct value chains: cell therapy initiatives like CAR-T manufacturing and stem cell expansion mandate ultra-gentle dissociation protocols, whereas cell-based research workflows accommodate more aggressive, high-yield methods. Clinical diagnostics, spanning flow cytometry to histopathology, require reproducible sample quality, and drug screening applications, from high-throughput screening to target validation, prioritize rapid processing and scalability. Finally, the market's end users-academic and research institutes, contract research organizations, hospitals and diagnostic centers, and pharmaceutical and biotech companies-all drive demand dynamics based on their unique operational imperatives.

Uncovering Regional Dynamics Across Americas Europe Middle East & Africa and Asia-Pacific Shaping Cell Dissociation Adoption Trends

The Americas continue to lead in both innovation and demand, buoyed by robust funding for cell therapy research and widespread adoption of automated dissociation systems. Key markets in North America benefit from integrated supply networks, early-stage technology adoption, and a strong regulatory environment that supports research-grade and clinical-grade tool development. Additionally, Latin American research centers increasingly invest in cost-effective dissociation workflows to support local academic and biopharma initiatives, signaling diversified growth potential.

In Europe, Middle East & Africa, regional collaboration networks facilitate cross-border clinical studies and technology validation efforts. EU research grants and consortium projects foster standardization of dissociation protocols, while Middle Eastern innovation hubs explore novel reagent chemistries. African research institutions, though operating with constrained budgets, adopt manual and hybrid dissociation approaches to pursue regionally relevant diagnostics and infectious disease research, laying the groundwork for future technology transfers.

Asia-Pacific exhibits dynamic expansion driven by increasing life sciences infrastructure investment and a growing base of contract research organizations. Local reagent manufacturers are emerging to serve the high-volume demands of cell-based research and drug discovery. Government initiatives across China, Japan, South Korea, and Australia emphasize precision medicine and single-cell analytics, fueling adoption of both enzymatic and mechanical dissociation techniques. Collectively, these regional dynamics underscore a geography-specific interplay of funding, regulation, and innovation that shapes market trajectories.

Profiling Leading Innovators and Strategic Collaborators Driving Breakthroughs and Market Leadership in Cell Dissociation Technologies

Leading technology providers have pursued differentiated strategies to fortify their positions in the cell dissociation arena. One prominent firm has focused on modular automated platforms that integrate advanced sensor arrays, enabling real-time protocol adjustments and remote monitoring capabilities. By coupling these instruments with proprietary reagent formulations, it has carved out a value proposition centered on high reproducibility and seamless workflow integration.

Another major player has invested heavily in strategic acquisitions to expand its enzymatic reagent portfolio, targeting companies with niche expertise in collagenase and DNase production. This vertical integration strategy has not only broadened its product range but also optimized supply chain control, delivering cost efficiencies that translate into competitive pricing. Concurrently, collaborative agreements with academic institutions bolster its pipeline of novel dissociation chemistries and validate emerging applications in clinical diagnostics.

Emerging innovators are carving out regional leadership by tailoring solutions to local market requirements. In Asia-Pacific, a rising manufacturer has gained traction by offering entry-level automated dissociators at accessible price points, complemented by region-specific technical support. Across Europe, a specialist reagent provider has aligned its product development roadmap with evolving regulatory guidelines, emphasizing GMP-compliant enzyme blends for cell therapy manufacturing. These diverse strategic approaches highlight the multiplicity of pathways to growth and differentiation in this evolving market.

Implementing Targeted Strategic Initiatives to Enhance Operational Efficiency Foster Innovation and Secure Competitive Advantage in Cell Dissociation

Investing in supply chain resilience emerges as a foundational recommendation for industry leaders. By diversifying procurement channels and forging partnerships with regional suppliers, organizations can mitigate the impact of future tariff shifts and logistical disruptions. Incorporating nearshoring or dual-sourcing strategies for critical enzymes and instrument components will enhance operational stability and provide flexibility in response to regulatory changes.

Accelerating adoption of integrated automation and data analytics is critical to stay ahead of performance benchmarks. Stakeholders should evaluate platform-agnostic software solutions that aggregate dissociation metrics, enabling continuous protocol refinement. Embracing predictive modeling and machine learning for process optimization will unlock new efficiencies in yield and viability, empowering teams to iterate rapidly and maintain competitive differentiation.

Cultivating collaborative R&D ecosystems offers another avenue for strategic advantage. Engaging with academic consortia, biopharma partners, and regulatory bodies can expedite product validation and harmonize quality standards. Shared innovation initiatives, such as co-development agreements for novel reagent chemistries, can reduce time to market and amplify collective expertise.

Finally, building a skilled workforce capable of navigating complex dissociation workflows is essential. Investing in targeted training programs that cover both theoretical underpinnings and hands-on instrumentation fosters a culture of best practice and continuous improvement. By aligning talent development with technological innovation, organizations will be well positioned to capitalize on emerging opportunities in cell-based therapies, diagnostics, and research applications.

Detailing the Comprehensive Multi-Modal Research Framework Integrating Primary Insights Secondary Data and Rigorous Validation for Robust Analysis

Our research framework blends primary engagement with industry experts, secondary literature analysis, and rigorous validation protocols to ensure comprehensive, reliable insights. Initially, we conducted in-depth interviews with senior R&D leaders, product managers, and procurement specialists across the cell dissociation value chain to capture firsthand perspectives on technological trends, supply chain considerations, and unmet market needs.

Complementing these discussions, an extensive review of peer-reviewed journals, patent filings, and regulatory filings provided context on emerging reagent chemistries, instrumentation innovations, and compliance requirements. We then applied data triangulation techniques, cross-referencing quantitative indicators from trade databases with qualitative inputs from expert panels to identify convergence points and divergences in stakeholder viewpoints.

To enhance analytical rigor, a multi-disciplinary advisory board comprising tissue engineering academicians, process development scientists, and commercial strategy consultants reviewed preliminary findings. Their feedback guided iterative refinements to our segmentation logic, regional assessments, and competitive mapping. This holistic approach ensures that the report's conclusions and recommendations rest on a solid foundation of validated evidence and expert consensus.

Synthesizing Critical Findings and Future Outlook to Empower Decision Makers Navigating the Evolving Dynamics of Cell Dissociation Innovations

The convergence of advanced instrumentation, tailored reagent systems, and shifting trade policies is reshaping the cell dissociation landscape in profound ways. As automated dissociators become more intelligent and modular, and enzyme formulations more selective, the market is poised to deliver greater throughput, reproducibility, and application-specific performance. Simultaneously, the imposition of new tariffs has underscored the importance of supply chain agility and strategic sourcing decisions.

Segmented insights reveal nuanced opportunities across tissue types, technology modalities, and end-user personas. Regional analyses highlight the varied market drivers in the Americas, EMEA, and Asia-Pacific, each presenting unique growth trajectories. Competitive profiling showcases diverse strategic approaches, from integration and acquisition to localized innovation and regulatory alignment.

Looking ahead, organizations that proactively embrace integrated workflows, invest in resilient procurement structures, and foster collaborative ecosystems will be best equipped to navigate emerging challenges. By coupling technical excellence with strategic foresight, decision makers can unlock new avenues for innovation and secure a leadership position in the rapidly evolving realm of cell dissociation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Customizable microfluidic devices enabling high-throughput single-cell dissociation and analysis workflows
  • 5.2. Emergence of enzyme-free mechanical dissociation systems to preserve cell viability in sensitive primary cultures
  • 5.3. Development of high-purity reagent kits with low endotoxin levels for regulatory compliant cell dissociation processes
  • 5.4. Implementation of automated closed sterile dissociation workstations with integrated HEPA filtration and environmental monitoring
  • 5.5. Development of specialized proteolytic enzyme blends for efficient dissociation of fibrotic human cardiac tissues
  • 5.6. Adoption of single-use disposable dissociation consumable kits to minimize cross-contamination and validation time
  • 5.7. Integration of real-time electrical impedance sensors in dissociation devices for precise tissue breakdown control
  • 5.8. Scaling up modular enzymatic dissociation platforms for industrial biomanufacturing of CAR-T cell therapies
  • 5.9. Development of gentle dissociation protocols combining low-shear flow reactors and tailored chelating agents for neural tissues
  • 5.10. Use of integrated optical monitoring modules to assess cell viability and dissociation efficiency in real time

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Cell Dissociation Market, by Type

  • 8.1. Introduction
  • 8.2. Cell Detachment
  • 8.3. Tissue Dissociation

9. Cell Dissociation Market, by Product

  • 9.1. Introduction
  • 9.2. Instruments
    • 9.2.1. Automated Dissociators
    • 9.2.2. Manual Tissue Grinders
  • 9.3. Kits
    • 9.3.1. Multiplex Kits
    • 9.3.2. Single-Use Kits
  • 9.4. Reagents
    • 9.4.1. Buffers
    • 9.4.2. Enzymes

10. Cell Dissociation Market, by Tissue Type

  • 10.1. Introduction
  • 10.2. Connective Tissue
  • 10.3. Epithelial Tissue
  • 10.4. Muscle Tissue
  • 10.5. Nervous Tissue

11. Cell Dissociation Market, by Technology

  • 11.1. Introduction
  • 11.2. Chemical
    • 11.2.1. Chelating Agents
    • 11.2.2. Osmotic Agents
    • 11.2.3. Surfactants
  • 11.3. Enzymatic
    • 11.3.1. Collagenase
    • 11.3.2. Dispase
    • 11.3.3. DNase
    • 11.3.4. Trypsin
  • 11.4. Mechanical
    • 11.4.1. Filtration
    • 11.4.2. Shear
    • 11.4.3. Ultrasonic

12. Cell Dissociation Market, by Application

  • 12.1. Introduction
  • 12.2. Cell Therapy
    • 12.2.1. Car-T Manufacturing
    • 12.2.2. Stem Cell Expansion
  • 12.3. Cell-Based Research
  • 12.4. Clinical Diagnostics
    • 12.4.1. Flow Cytometry
    • 12.4.2. Histopathology
  • 12.5. Drug Screening
    • 12.5.1. High-Throughput Screening
    • 12.5.2. Target Validation

13. Cell Dissociation Market, by End User

  • 13.1. Introduction
  • 13.2. Academic & Research Institutes
  • 13.3. Contract Research Organizations
  • 13.4. Hospitals & Diagnostic Centers
  • 13.5. Pharmaceutical & Biotech Companies

14. Americas Cell Dissociation Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Cell Dissociation Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Cell Dissociation Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Corning Incorporated
    • 17.3.2. Merck KGaA
    • 17.3.3. Becton, Dickinson and Company
    • 17.3.4. Thermo Fisher Scientific Inc.
    • 17.3.5. Abeomics Inc.
    • 17.3.6. Captivate Bio, LLC
    • 17.3.7. Cell Signaling Technology, Inc.
    • 17.3.8. Celprogen Corporation
    • 17.3.9. Central Drug House. (P) Ltd.
    • 17.3.10. Genaxxon bioscience GmbH
    • 17.3.11. HiMedia Laboratories Private Limited
    • 17.3.12. Innovative Cell Technologies, Inc.
    • 17.3.13. Neuromics
    • 17.3.14. Novo Nordisk A/S
    • 17.3.15. PAN-Biotech GmbH
    • 17.3.16. REPROCELL Inc.
    • 17.3.17. RWD Life Science Co., Ltd.
    • 17.3.18. Sartorius AG
    • 17.3.19. ScienCell Research Laboratories, Inc.
    • 17.3.20. Stemmera Inc.
    • 17.3.21. VitaCyte, LLC
    • 17.3.22. VWR International, LLC
    • 17.3.23. Worthington Biochemical Corporation

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

LIST OF FIGURES

  • FIGURE 1. CELL DISSOCIATION MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 20. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 27. CELL DISSOCIATION MARKET: RESEARCHAI
  • FIGURE 28. CELL DISSOCIATION MARKET: RESEARCHSTATISTICS
  • FIGURE 29. CELL DISSOCIATION MARKET: RESEARCHCONTACTS
  • FIGURE 30. CELL DISSOCIATION MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. CELL DISSOCIATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL DETACHMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL DETACHMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE DISSOCIATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE DISSOCIATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL DISSOCIATION MARKET SIZE, BY AUTOMATED DISSOCIATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CELL DISSOCIATION MARKET SIZE, BY AUTOMATED DISSOCIATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MANUAL TISSUE GRINDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MANUAL TISSUE GRINDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL DISSOCIATION MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CELL DISSOCIATION MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MULTIPLEX KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MULTIPLEX KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SINGLE-USE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SINGLE-USE KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL DISSOCIATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CELL DISSOCIATION MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL DISSOCIATION MARKET SIZE, BY BUFFERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CELL DISSOCIATION MARKET SIZE, BY BUFFERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CONNECTIVE TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CONNECTIVE TISSUE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL CELL DISSOCIATION MARKET SIZE, BY EPITHELIAL TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CELL DISSOCIATION MARKET SIZE, BY EPITHELIAL TISSUE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MUSCLE TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MUSCLE TISSUE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL CELL DISSOCIATION MARKET SIZE, BY NERVOUS TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CELL DISSOCIATION MARKET SIZE, BY NERVOUS TISSUE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CHELATING AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CHELATING AGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL CELL DISSOCIATION MARKET SIZE, BY OSMOTIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CELL DISSOCIATION MARKET SIZE, BY OSMOTIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SURFACTANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SURFACTANTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COLLAGENASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COLLAGENASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DISPASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DISPASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DNASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DNASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TRYPSIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TRYPSIN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL CELL DISSOCIATION MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CELL DISSOCIATION MARKET SIZE, BY FILTRATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SHEAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SHEAR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ULTRASONIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CAR-T MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CAR-T MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL CELL DISSOCIATION MARKET SIZE, BY STEM CELL EXPANSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CELL DISSOCIATION MARKET SIZE, BY STEM CELL EXPANSION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL-BASED RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL-BASED RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL CELL DISSOCIATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CELL DISSOCIATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS CELL DISSOCIATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS CELL DISSOCIATION MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 137. AMERICAS CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2025-2030 (USD MILLION)
  • TABLE 139. AMERICAS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2025-2030 (USD MILLION)
  • TABLE 141. AMERICAS CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2025-2030 (USD MILLION)
  • TABLE 151. AMERICAS CELL DISSOCIATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS CELL DISSOCIATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 187. CANADA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. CANADA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 189. CANADA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 190. CANADA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 191. CANADA CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 192. CANADA CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 193. CANADA CELL DISSOCIATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 194. CANADA CELL DISSOCIATION MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
  • TABLE 195. CANADA CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 196. CANADA CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 197. CANADA CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. CANADA CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
  • TABLE 199. CANADA CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. CANADA CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 201. CANADA CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2018-2024 (USD MILLION)
  • TABLE 202. CANADA CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2025-2030 (USD MILLION)
  • TABLE 203. CANADA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2018-2024 (USD MILLION)
  • TABLE 204. CANADA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2025-2030 (USD MILLION)
  • TABLE 205. CANADA CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 206. CANADA CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2025-2030 (USD MILLION)
  • TABLE 207. CANADA CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. CANADA CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 209. CANADA CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 210. CANADA CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 211. CANADA CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 212. CANADA CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 213. CANADA CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2018-2024 (USD MILLION)
  • TABLE 214. CANADA CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2025-2030 (USD MILLION)
  • TABLE 215. CANADA CELL DISSOCIATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. CANADA CELL DISSOCIATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 217. MEXICO CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. MEXICO CELL DISSOCIATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 219. MEXICO CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 220. MEXICO CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 221. MEXICO CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 222. MEXICO CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 223. MEXICO CELL DISSOCIATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 224. MEXICO CELL DISSOCIATION MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
  • TABLE 225. MEXICO CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 226. MEXICO CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 227. MEXICO CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. MEXICO CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. MEXICO CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. MEXICO CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 231. MEXICO CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2018-2024 (USD MILLION)
  • TABLE 232. MEXICO CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2025-2030 (USD MILLION)
  • TABLE 233. MEXICO CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2018-2024 (USD MILLION)
  • TABLE 234. MEXICO CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2025-2030 (USD MILLION)
  • TABLE 235. MEXICO CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 236. MEXICO CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2025-2030 (USD MILLION)
  • TABLE 237. MEXICO CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. MEXICO CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 239. MEXICO CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 240. MEXICO CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 241. MEXICO CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 243. MEXICO CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2018-2024 (USD MILLION)
  • TABLE 244. MEXICO CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2025-2030 (USD MILLION)
  • TABLE 245. MEXICO CELL DISSOCIATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. MEXICO CELL DISSOCIATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 247. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. BRAZIL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 250. BRAZIL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 251. BRAZIL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 252. BRAZIL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 253. BRAZIL CELL DISSOCIATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 254. BRAZIL CELL DISSOCIATION MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
  • TABLE 255. BRAZIL CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 257. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
  • TABLE 259. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 261. BRAZIL CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2025-2030 (USD MILLION)
  • TABLE 263. BRAZIL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2018-2024 (USD MILLION)
  • TABLE 264. BRAZIL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2025-2030 (USD MILLION)
  • TABLE 265. BRAZIL CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 266. BRAZIL CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2025-2030 (USD MILLION)
  • TABLE 267. BRAZIL CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 269. BRAZIL CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 270. BRAZIL CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 271. BRAZIL CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 272. BRAZIL CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 273. BRAZIL CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2018-2024 (USD MILLION)
  • TABLE 274. BRAZIL CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2025-2030 (USD MILLION)
  • TABLE 275. BRAZIL CELL DISSOCIATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. BRAZIL CELL DISSOCIATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 277. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 279. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 281. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 282. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 283. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 284. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
  • TABLE 285. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 286. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 287. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
  • TABLE 289. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 290. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 291. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2018-2024 (USD MILLION)
  • TABLE 292. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2025-2030 (USD MILLION)
  • TABLE 293. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2018-2024 (USD MILLION)
  • TABLE 294. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2025-2030 (USD MILLION)
  • TABLE 295. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 296. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2025-2030 (USD MILLION)
  • TABLE 297. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 299. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 300. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 301. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 302. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 303. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2018-2024 (USD MILLION)
  • TABLE 304. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2025-2030 (USD MILLION)
  • TABLE 305. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY CHEMICAL, 2025-2030 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC, 2025-2030 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY MECHANICAL, 2025-2030 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY DRUG SCREENING, 2025-2030 (USD MILLION)
  • TABLE 335. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 339. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 341. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 342. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 343. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 345. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 346. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
  • TABLE 347. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 348. UNITED KINGDOM CELL DISSOCIATION MARKET